Assembly Bill A5218

2023-2024 Legislative Session

Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2023-A5218 (ACTIVE) - Details

Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §2803-c, Pub Health L
Versions Introduced in Other Legislative Sessions:
2019-2020: A8932
2021-2022: A6628

2023-A5218 (ACTIVE) - Summary

Designates an individual to be notified in the case of dose or brand change for psychotropic medication.

2023-A5218 (ACTIVE) - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5218
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                               March 7, 2023
                                ___________
 
 Introduced   by  M.  of  A.  BARCLAY,  MANKTELOW,  LEMONDES,  DeSTEFANO,
   J. M. GIGLIO, BLANKENBUSH -- read once and referred to  the  Committee
   on Health
 
 AN  ACT  to  amend  the public health law, in relation to designating an
   individual to be notified in the case of  dose  or  brand  change  for
   psychotropic medication

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 3 of section 2803-c of the public health law is
 amended by adding a new paragraph s to read as follows:
   S. (I) PURSUANT TO REGULATIONS PROMULGATED BY THE COMMISSIONER,  EVERY
 PATIENT  SHALL  HAVE THE RIGHT TO DESIGNATE AN INDIVIDUAL TO BE NOTIFIED
 IN THE EVENT THAT THE FACILITY REDUCES THE DOSE OR CHANGES THE BRAND  OR
 FORM  OF  THE PATIENT'S PSYCHOTROPIC MEDICATION. SUCH NOTIFICATION SHALL
 INCLUDE A WARNING LISTING POSSIBLE SIDE EFFECTS AND  DRUG  INTERACTIONS,
 INCLUDING  SIDE EFFECTS UPON DISCONTINUATION OF SUCH DRUGS. NOTIFICATION
 SHALL BE MADE IN WRITING, AND SHALL NOT BE EFFECTIVE  UNTIL  RECEIPT  OF
 THE WRITTEN CONSENT OF THE DESIGNATED INDIVIDUAL. IN THE CASE OF A GRAD-
 UAL  DOSE  REDUCTION,  A  DESIGNEE  SHALL CHECK A BOX ACKNOWLEDGING SUCH
 DESIGNEE HAS BEEN GIVEN A COPY OF THE RIGHTS PERTAINING TO GRADUAL  DOSE
 REDUCTIONS.
   (II)  FOR  THE  PURPOSES  OF THIS PARAGRAPH, "PSYCHOTROPIC MEDICATION"
 MEANS A MEDICATION THAT IS ADMINISTERED FOR  THE  PURPOSE  OF  AFFECTING
 BRAIN  ACTIVITIES ASSOCIATED WITH MENTAL PROCESSES AND BEHAVIOR, INCLUD-
 ING, BUT NOT LIMITED TO, ANTI-PSYCHOTICS, ANTI-DEPRESSANTS, ANXIOLYTICS,
 SEDATIVES AND HYPNOTICS.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04918-01-3

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.